Megan Wiesel, PA
Medical · Las Vegas, NVNPI 1528060225
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,204 of the $19,386 with a category attached, or 78.4%. It is spread thinly across 36 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 880 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- UCB, Inc.$1K
- Sun Pharmaceutical Industries Inc.$1K
- LNHC, Inc$1K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $10K from 30 others
What the payments were for
- Consulting fees$2,10211%
- Speaking & faculty fees$1,2006%
- Food & beverage$15,20478%
- Education$8805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 152 | $3,339 |
| Johnson & Johnson | 102 | $1,799 |
| UCB, Inc. | 40 | $1,235 |
| Sun Pharmaceutical Industries Inc. | 52 | $1,227 |
| LNHC, Inc | 1 | $1,200 |
| E.r. Squibb & Sons, L.L.C. | 62 | $1,072 |
| Sanofi | 41 | $1,046 |
| Incyte Corporation | 48 | $941 |
| Galderma Laboratories, L.p. | 40 | $908 |
| Novartis | 46 | $871 |
| Arcutis Biotherapeutics, Inc. | 65 | $848 |
| EPI Health, LLC | 1 | $750 |
| Pfizer | 52 | $676 |
| LEO Pharma Inc. | 34 | $673 |
| Amgen | 31 | $532 |
| Regeneron Healthcare Solutions, Inc. | 20 | $358 |
| Lilly USA, LLC | 22 | $349 |
| Dermavant Sciences, Inc. | 27 | $324 |
| Almirall LLC | 6 | $290 |
| Journey Medical Corporation | 4 | $173 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $118 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $116 |
| VYNE Pharmaceuticals Inc. | 2 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Organon | 4 | $62 |
| Krystal Biotech Inc | 3 | $55 |
| GSK | 2 | $48 |
| Verrica Pharmaceuticals Inc. | 2 | $41 |
| Dermira, Inc. | 2 | $39 |
| Botanix SB Inc | 1 | $31 |
| Chiesi USA, Inc. | 1 | $26 |
| Merz North America, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Smith+Nephew | 1 | $14 |
| Biofrontera Inc. | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,386 in reported general payments places this provider in the 95th percentile of 250 medical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 27 | $601,049 |
| Humira(Cf) PenAdalimumab | 14 | $97,412 |
| Dupixent PenDupilumab | 25 | $97,220 |
| Dupixent SyringeDupilumab | 16 | $61,362 |
| Metronidazole | 69 | $5,355 |
| Ketoconazole | 249 | $4,327 |
| Clobetasol Propionate | 125 | $4,185 |
| Fluorouracil | 26 | $1,509 |
| Ciclopirox | 69 | $1,479 |
| Doxycycline Monohydrate | 117 | $1,285 |
| Mometasone Furoate | 71 | $1,268 |
| Halobetasol Propionate | 11 | $1,247 |
| Clindamycin Phosphate | 45 | $1,129 |
| Triamcinolone Acetonide | 109 | $916 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 23 | $278 |
Paid to pharmacies, not to this prescriber.
Other medical in Las Vegas
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Tai PhamLas Vegas$16K
- Eric HilmesLas Vegas$15K
- Wardon OjedapoLas Vegas$12K
- Melchor GochiocoLas Vegas$11K
- Keesha KaplanLas Vegas$11K
- Adelbert WadsworthLas Vegas$11K
- Isaac TunnellLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.